22 May 2019

Mitral valve replacement and repair

Tendyne - Journey toward a tailored transcatheter therapy selection part II: from mitral repair to replacement

Sponsored by Abbott

Chairpersons: T. Modine, N. Piazza

Panellists: V. Badhwar, N. Dumonteil, M. Goessl, T. Walther

SHOW MORE

Summary

Consult this session on Tendyne Transcatheter Mitral Valve Implantation (TMVI) system and learn how it has expanded the ability to treat diverse mitral pathologies.

Learning Objectives

To learn about the largest TMVI body of evidence and patho-anatomical criteria for the transcatheter repair vs. replacement therapy selection
To learn how Tendyne has expanded the ability to treat diverse mitral pathologies
To learn how to identify baseline clinical features associated with positive outcomes post-Tendyne TMVI

Presentations available when logged in:

What have we learnt from the largest TMVI clinical program today?
COAPT implications for TMVI clinical programs
Patho–anatomical criteria for Tendyne TMVI therapy
Predictors of one-year outcomes post-Tendyne TMVI
How is Tendyne breaking boundaries in treating a broad range of mitral pathologies?
Challenging mitral regurgitation procedure presentations

Log in or create account for free

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…